AnticoaguLation ONE year after ablation of atrial fibrillation in patients with Atrial Fibrillation (ALONE AF study)

Not Applicable

Recruiting

• Conditions: Diseases of the circulatory system

• Registration Number: KCT0005142
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 840

Inclusion Criteria

1. no recurrence of atrial fibrillation one year after catheter ablation of atrial fibrillation
2. CHA2DS2-VASc score >=1 (male) or >=2 (female)
3. age: 19 to 80 years
4. non-valvular atrial fibrillation
5. those who consent the study.
6. those who can be followed after enrollement

Exclusion Criteria

1. Severe liver or kidney dysfunction
2. Thyroid dysfunction
3. Pregnant or breastfeeding women
4. Malignant tumors that have not been completely cured
5. Severe structural heart disease
6. Predicted survival is less than 12 months
7. Patients who do not understand the content of the study or disagree with it

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
composite outcome including stroke/systemic embolism and major bleeding

Secondary Outcome Measures

Name	Time	Method
systemic embolism;major bleeding